#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodegenerative disorder Mantle cell lymphoma stage IV Ornithine transcarbamoylase deficiency Li-Fraumeni syndrome Acute respiratory distress syndrome Congenital ectodermal dysplasia VEXAS syndrome Autoimmune haemolytic anaemia KBG syndrome Bronchopulmonary aspergillosis Primary immunodeficiency syndrome Endometrial adenocarcinoma Rhabdomyosarcoma recurrent Thermal burn Cystic fibrosis gastrointestinal disease More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Basic Information Breast angiosarcoma metastatic – Trials in Disease Lennox-Gastaut syndrome – Treatment Indolent systemic mastocytosis – Diagnostics Alagille syndrome – Trials in Disease Short-bowel syndrome – Diagnostics Cystic fibrosis lung – Diagnostics Breast angiosarcoma – Basic Information Nodal marginal zone B-cell lymphoma – Trials in Disease Alexander disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lacnotuzumab Camphor L-ALANINE Deutivacaftor [18F]Mc225 Sacituzumab Govitecan Moxifloxacin Esketamine Hydrochloride Cat Epithelia Zoledronic Acid Alternaria Alternata (402) Benzylpenicillin Gsk3965193B 68Ga-Dpi-4452 Netupitant Pivekimab Sunirine Erlotinib Daunorubicin Hydrochloride Dexrazoxane Immunostimulants More therapies…

    Learn about Your Condition

    Constipation Progressive multiple sclerosis Follicular lymphoma stage IV Viral infection Pleomorphic leiomyosarcoma Skin wrinkling Liver transplant rejection Acute myocardial infarction Acute cardiac event Immune thrombocytopenia Hepatitis alcoholic Hydrocele IgA nephropathy Cataract Lichenoid keratosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A Study of Intravenous Lidocaine to Reduce Inflammation in Patients Undergoing Heart Valve or Coronary Artery Bypass Surgery with Heart-Lung Machine

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac valve disease
    • Coronary artery disease
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain

  • A Study Comparing BGB-16673 to Pirtobrutinib for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • BGB-16673
    • Pirtobrutinib
    Austria Belgium France Germany Italy The Netherlands +4

  • Study of dapagliflozin and semaglutide to reverse prediabetes to normal blood sugar levels in patients with coronary artery disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    • Coronary artery disease
    Investigated Drugs:
    • Dapagliflozin
    • Semaglutide
    Denmark

  • Study of zanidatamab with drug combination for patients with HER2 and PD-L1 positive advanced gastroesophageal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Folic Acid
    • Fluorouracil
    • Oxaliplatin
    Germany

  • A Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments

    Recruiting

    1 1 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    • Rheumatoid arthritis
    • Systemic scleroderma
    Germany

  • A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

    Recruiting

    2 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • GS-248
    • VIPOGLANSTAT
    Bulgaria Czechia Hungary Italy Poland Romania
Previous Page
1 … 94 95 96 97 98 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!